-
1
Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases
Published 2016-07-01Get full text
Article -
2
-
3
Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
Published 2025-02-01Subjects: “…Anti-cancer drugs…”
Get full text
Article -
4
Determination of 5-fluorouracil anticancer drug solubility in supercritical CO 2 using semi-empirical and machine learning models
Published 2025-02-01Subjects: “…5-fluorouracil anti-cancer drug…”
Get full text
Article -
5
Design and synthesis of phenylthiophosphoryl dichloride derivatives and evaluation of their antitumour and anti-inflammatory activities
Published 2025-01-01“…Compound S11 can be used as a new chemical entity for the discovery of new anti-cancer drugs or anti-inflammatory drugs.…”
Get full text
Article -
6
An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival
Published 2015-07-01“…Apoptosis resistance is a hallmark of human cancer, and tumor cells often become resistant due to defects in the programmed cell death machinery.Targeting key apoptosis regulators to overcome apoptotic resistance and promote rapid death of tumor cells is an exciting new strategy for cancer treatment, either alone or in combination with traditionally used anti-cancer drugs that target cell division. Here we present a multiscale modeling framework for investigating the synergism between traditional chemotherapy and targeted therapies aimed at critical regulators of apoptosis.…”
Get full text
Article -
7
The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis
Published 2023-07-01“…Although early detection improves the survival rate to around 90%, late detection would mean the need to use chemotherapy or radiotherapy, especially if surgery is not feasible. 5-fluorouracil (5-FU) is one of the common anti-cancer drugs used in treating CRC. It is the drug that has the greatest efficacy on CRC. …”
Get full text
Article -
8
Algebraic and topological indices of molecular pathway networks in human cancers
Published 2015-07-01“…Our results can aide in identification of promising targets for anti-cancer drugs. Beyond that, we provide a unifying framework to study protein-protein interaction networks of families of related diseases (e.g. neurodegenerative diseases, viral diseases, substance abuse disorders).…”
Get full text
Article -
9
Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment
Published 2025-01-01“…They can also be easily conjugated to anti-cancer drugs, targeting agents, or genetic vectors that respond to specific stimuli or pH changes. …”
Get full text
Article -
10
Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
Published 2024-01-01“…Streptomyces have been presented as a great source of antibiotics and anti-cancer drugs over the past century. Especially Streptomyces living in adverse conditions produce certain metabolites with cytolytic and anti-microbial activities, which have been utilised for manufacturing antimicrobial and anticancer drugs. …”
Get full text
Article -
11
Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment
Published 2025-01-01“…In this review, we highlighted the anti-cancer components (plumbagin, quercetin, resveratrol, curcumin, xanthatin, carvacrol, telmisartan, and sulforaphane) that modulate ROS levels and the recent targeting platforms used to increase the application of anti-cancer drugs and the developed delivery platforms with diverse mechanisms of action. …”
Get full text
Article -
12
Effects of silkworm pupa protein on apoptosis and energy metabolism in human colon cancer DLD-1 cells
Published 2022-09-01“…Conclusion: SPP can cause oxidative damage, promote apoptosis, and reduce mitochondrial respiratory and glycolysis rate in colon cancer DLD-1 cells, which reveals that SPP has the potential to serve as the anti-cancer drugs in the future, but further experimental evidence is needed.…”
Get full text
Article -
13
Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
Published 2025-01-01“…This project has the goal of characterizing the systemic and tissue exposure of four anti-cancer drugs in humans using a PBPK platform fed with data from the literature. …”
Get full text
Article -
14
Six events that shaped antibody approvals in oncology
Published 2025-02-01“…A little over twenty-five years ago, the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) approved the chimeric antibody rituximab which fundamentally altered the landscape of anti-cancer drugs. While only a few antibodies were approved in the immediate years that followed the rituximab approval, the last decade saw a wave of antibody-drug approvals in the oncology arena. …”
Get full text
Article -
15
Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53
Published 2025-01-01“…We further explore drug repurposing screens of FDA-approved anti-cancer drugs to develop NR2E3-targeted combinatorial treatments, such as the 11a-Romidepsin combination in HeLa cells. …”
Get full text
Article -
16
Synthesis of Some Metal Complexes with New Heterocyclic Ligand (5-(((2-(3-(1<i>H</i>-indol-3-yl)acryloyl)phenyl)amino)methylene)-2-thiooxodihydropyrimidine-4,6(1<i>H</i>,5<i>H</i>)...
Published 2025-01-01“…The present investigation employs a comprehensive molecular docking analysis to assess the binding energies of anti-cancer drugs, thereby elucidating their binding affinity towards the receptor. …”
Get full text
Article -
17
Recent progress on anti-cancer activity of thiadiazoles: A review
Published 2025-01-01“…These compounds are frequently utilized when combined with other anti-cancer drugs to improve their efficacy. Thiadiazoles exhibit beneficial synergistic effects when used with other anticancer treatments like chemotherapy or targeted therapy. …”
Get full text
Article -
18
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism
Published 2025-02-01“…At last, MDCs with various anti-cancer drugs are formulated with their safety and anti-tumor efficacy validated in multiple syngeneic mice and orthotopic human tumor models via different routes of administration. …”
Get full text
Article -
19
Evaluation of the merit of ethanolic extract of Annona reticulata as an anti-cancer agent in human colon cancer cell lines (HCT-116) [version 2; peer review: 2 approved, 1 not appr...
Published 2024-06-01“…Novel alternative therapeutic anti-cancer drugs against colon cancer with less toxicity are to be explored . …”
Get full text
Article -
20
Mouse ZGRF1 helicase facilitates DNA repair and maintains efficient fertility
Published 2025-01-01“…In its absence, human cells exhibit greater sensitivity towards anti-cancer drugs such as mitomycin C and camptothecin. …”
Get full text
Article